Work

Long‐acting contraception in adolescents and young women with type 1 and type 2 diabetes

Year: 2020

Type: review

Abstract: Adolescent pregnancy is a major public health problem worldwide. Adolescents living with diabetes are not aware of the risks of unplanned pregnancy and the high rate of fetal and maternal complications when gestation occurs in women with significant hyperglycemia. These data highlight the significance of pregnancy prevention in young women with diabetes. Long-acting reversible contraceptives (LARCs), which include subdermal progestin implants and hormonal and nonhormonal intrauterine devices (IUDs), have been recommended by the American College of Obstetricians Gynecologists and the American Academy of Pediatrics as a first-line contraceptive option for adolescents and young women. This article reviews LARC options for adolescents and young women with type 1 (T1D) and type 2 (T2D) diabetes as well as the possible complications and side effects.

Source: Pediatric Diabetes

DOI: 10.1111/pedi.13069

Authors: Abril Salinas, Paulina M. Merino, Franco Giraudo, Ethel Codner

Institutions: Instituto Chileno de Medicina Reproductiva, University of Chile

Language: English

Topic: Reproductive Health and Contraception

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Fondo Nacional de Desarrollo Científico y Tecnológico